# Advanced Development of a Multivalent Vaccine Candidate for Filovirus and Lassa Fever

> **NIH NIH N01** · THOMAS JEFFERSON UNIVERSITY · 2024 · $917,204

## Abstract

To support advanced development of a multivalent vaccine candidates for Filovirus and Lassa Fever. This contract may support formulation and manufacture of the individual vaccine components, as well as stability testing, nonclinical immunogenicity and efficacy testing in nonhuman primates, IND enabling GLP repeated dose toxicology, submission of an IND and eventual clinical evaluation.

## Key facts

- **NIH application ID:** 11041880
- **Project number:** 272201700082C-P00021-9999-1
- **Recipient organization:** THOMAS JEFFERSON UNIVERSITY
- **Principal Investigator:** MAJA SUNDBERG
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $917,204
- **Award type:** —
- **Project period:** 2017-09-01 → 2025-12-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/11041880

## Citation

> US National Institutes of Health, RePORTER application 11041880, Advanced Development of a Multivalent Vaccine Candidate for Filovirus and Lassa Fever (272201700082C-P00021-9999-1). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/11041880. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*